Loading
Latest filing published 11 Jun 2025 for Apimeds Pharmaceuticals US, Inc., €167k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Inscobee Inc. on record concern Apimeds Pharmaceuticals US, Inc. In total, 2 filings cover trades dated 12 May 2025.
Purchases make up the whole of the open-market record (1 purchase, €1.8M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 11 June 2025 with a transaction (€167k) in Apimeds Pharmaceuticals US, Inc. The clock since the last published purchase (14 May 2025) now reads 522 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations